 |
|
|
| |
Prevalence and Impact of Baseline Resistance-Associated Variants on the Efficacy of Elbasvir/Grazoprevir in Hepatitis C Genotype 1-Infected Japanese Patients
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Yoshito Itoh1; Fumitaka Suzuki2; Yoshiyasu Karino3; Kazuaki Chayama4; Naoyoshi Yatsuzuka5; Etsuo Yodoya5; Go Fujimoto5; Stuart Black6; Ernest Asante-Appiah6; Janice Wahl6; Michael Robertson6; Hiromitsu Kumada2
1Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan; 2Department of Hepatology, Toranomon Hospital, Tokyo, Japan; 3Department of Gastroenterology, Sapporo Kosei General Hospital, Hokkaido, Japan; 4Department of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan; 5MSD K.K., Tokyo, Japan; 6Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
